DALY and QALY

Last updated: November 01, 2022

DALY and QALY

Revision for finals delete as I go

Revision for finals delete as I go

DNA synthesis inhibitors: Fluoroquinolones
DNA synthesis inhibitors: Metronidazole
Antimetabolites: Sulfonamides and trimethoprim
Cell wall synthesis inhibitors: Penicillins
Cell wall synthesis inhibitors: Cephalosporins
Type III hypersensitivity
Type IV hypersensitivity
Type I hypersensitivity
Type II hypersensitivity
Thymus histology
Viral structure and functions
Wound healing
Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Agonist, partial agonist and antagonist
Somatosensory pathways
Somatosensory receptors
Ascending and descending spinal tracts
Pyramidal and extrapyramidal tracts
Nervous system anatomy and physiology
Muscle spindles and golgi tendon organs
Sciatica
Anatomy of the cranial meninges and dural venous sinuses
Anatomy of the blood supply to the brain
Anatomy of the abdominal viscera: Blood supply of the foregut, midgut and hindgut
Blood histology
Anatomy of the brainstem
Optic pathways and visual fields
Anatomy and physiology of the eye
Cerebral circulation
Stroke: Clinical
Cranial nerves
Cranial nerves rap
Cranial nerve pathways
Pharmacokinetics: Drug absorption and distribution
Anatomy of the basal ganglia
Basal ganglia: Direct and indirect pathway of movement
Cerebellum
Anatomy of the cerebellum
Auditory transduction and pathways
Vestibular transduction
Complement system
Dementia and delirium: Clinical
Substance misuse and addiction: Clinical
Tricyclic antidepressants
Typical antipsychotics
Metabolic alkalosis
Seizures and epilepsy
Free radicals and cellular injury
Traumatic brain injury: Clinical
Concussion and traumatic brain injury
Schizophrenia
Major depressive disorder
Bone remodeling and repair
Lambert-Eaton myasthenic syndrome
Pediatric orthopedic conditions: Clinical
Bone histology
Skin histology
Colon histology
Stomach histology
Cartilage histology
Ovary histology
Paget disease of bone
Non-steroidal anti-inflammatory drugs
Osteomalacia and rickets
Osgood-Schlatter disease (traction apophysitis)
Slipped capital femoral epiphysis
Developmental dysplasia of the hip
Rotator cuff tear
Thoracic outlet syndrome
Klumpke paralysis
Erb-Duchenne palsy
Carpal tunnel syndrome
Compartment syndrome
Osteomyelitis
Osteoporosis
Lordosis, kyphosis, and scoliosis
Osteoarthritis
Rheumatoid arthritis
Gout
Ankylosing spondylitis
Muscular dystrophy
Inclusion body myopathy
Dermatomyositis
Fibromyalgia
Myasthenia gravis
Opioid agonists, mixed agonist-antagonists and partial agonists
Antigout medications
Osteoporosis medications
Brachial plexus
Anatomy of the brachial plexus
Rheumatoid arthritis: Clinical
Introduction to biostatistics
Types of data
Probability
Mean, median, and mode
Range, variance, and standard deviation
Standard error of the mean (Central limit theorem)
Normal distribution and z-scores
Paired t-test
Two-sample t-test
Hypothesis testing: One-tailed and two-tailed tests
One-way ANOVA
Two-way ANOVA
Repeated measures ANOVA
Correlation
Methods of regression analysis
Linear regression
Logistic regression
Spearman's rank correlation coefficient
Mann-Whitney U test
Kappa coefficient
Chi-squared test
Fisher's exact test
Kaplan-Meier survival analysis
Type I and type II errors
Sensitivity and specificity
Positive and negative predictive value
Test precision and accuracy
Incidence and prevalence
Relative and absolute risk
Odds ratio
Attributable risk (AR)
Mortality rates and case-fatality
DALY and QALY
Direct standardization
Indirect standardization
Study designs
Ecologic study
Cross sectional study
Case-control study
Cohort study
Randomized control trial
Clinical trials
Sample size
Placebo effect and masking
Disease causality
Selection bias
Information bias
Confounding
Interaction
Bias in interpreting results of clinical studies
Bias in performing clinical studies
Prevention
Anatomy of the pelvic girdle
Anatomy of the pelvic cavity
Arteries and veins of the pelvis
Anatomy of the male reproductive organs of the pelvis
Nerves and lymphatics of the pelvis
Anatomy clinical correlates: Male pelvis and perineum
Anatomy of the breast
Anatomy of the female urogenital triangle
Anatomy clinical correlates: Breast
Development of the reproductive system
Prostate gland histology
Penis histology
Testis, ductus deferens, and seminal vesicle histology
Mammary gland histology
Fallopian tube and uterus histology
Cervix and vagina histology
Anatomy and physiology of the male reproductive system
Testosterone
Anatomy and physiology of the female reproductive system
Estrogen and progesterone
Menstrual cycle
Menopause
Pregnancy
Stages of labor
Oxytocin and prolactin
Breastfeeding
Benign prostatic hyperplasia
Prostate cancer
Erectile dysfunction
Amenorrhea
Polycystic ovary syndrome
Premature ovarian failure
Endometritis
Endometriosis
Pelvic inflammatory disease
Preeclampsia & eclampsia
Placenta previa
Placental abruption
Potter sequence
Postpartum hemorrhage
Congenital cytomegalovirus (NORD)
Miscarriage
Ectopic pregnancy
Fetal alcohol syndrome
PDE5 inhibitors
Adrenergic antagonists: Alpha blockers
Estrogens and antiestrogens
Progestins and antiprogestins
Aromatase inhibitors
Uterine stimulants and relaxants
Newborn management: Clinical
Neonatal jaundice: Clinical
Human development days 1-4
Human development days 4-7
Human development week 2
Human development week 3
Ectoderm
Mesoderm
Endoderm
Development of the placenta
Development of the fetal membranes
Development of twins
Hedgehog signaling pathway
Development of the digestive system and body cavities
Development of the umbilical cord
Development of the cardiovascular system
Fetal circulation
Blood pressure, blood flow, and resistance
Pressures in the cardiovascular system
Resistance to blood flow
Compliance of blood vessels
Microcirculation and Starling forces
Stroke volume, ejection fraction, and cardiac output
Cardiac contractility
Frank-Starling relationship
Cardiac preload
Cardiac afterload
Law of Laplace
Cardiac cycle
Cardiac work
Pressure-volume loops
Changes in pressure-volume loops
Action potentials in myocytes
Action potentials in pacemaker cells
Cardiac conduction system
Cardiac conduction velocity
ECG basics
ECG normal sinus rhythm
ECG intervals
ECG axis
ECG rate and rhythm
ECG cardiac infarction and ischemia
ECG cardiac hypertrophy and enlargement
Baroreceptors
Chemoreceptors
ACE inhibitors, ARBs and direct renin inhibitors
Calcium channel blockers
Adrenergic antagonists: Beta blockers
cGMP mediated smooth muscle vasodilators
Class I antiarrhythmics: Sodium channel blockers
Class II antiarrhythmics: Beta blockers
Class III antiarrhythmics: Potassium channel blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Miscellaneous lipid-lowering medications
Positive inotropic medications
Anatomy of the larynx and trachea
Bones and joints of the thoracic wall
Vessels and nerves of the thoracic wall
Anatomy of the lungs and tracheobronchial tree
Kidney histology
Anatomy of the diaphragm
Anatomy clinical correlates: Thoracic wall
Anatomy clinical correlates: Pleura and lungs
Development of the respiratory system
Nasal cavity and larynx histology
Trachea and bronchi histology
Bronchioles and alveoli histology
Respiratory system anatomy and physiology
Reading a chest X-ray
Lung volumes and capacities
Anatomic and physiologic dead space
Alveolar surface tension and surfactant
Ventilation
Zones of pulmonary blood flow
Regulation of pulmonary blood flow
Pulmonary shunts
Ventilation-perfusion ratios and V/Q mismatch
Airflow, pressure, and resistance
Gas exchange in the lungs, blood and tissues
Alveolar gas equation
Diffusion-limited and perfusion-limited gas exchange
Oxygen binding capacity and oxygen content
Oxygen-hemoglobin dissociation curve
Carbon dioxide transport in blood
Upper respiratory tract infection
Congenital pulmonary airway malformation
Acute respiratory distress syndrome
Emphysema
Asthma
Bronchiectasis
Chronic bronchitis
Cystic fibrosis
Alpha 1-antitrypsin deficiency
Restrictive lung diseases
Pneumonia
Pancoast tumor
Pleural effusion
Pneumothorax
Pulmonary embolism
Pulmonary edema
Pulmonary hypertension
Sleep apnea
Antihistamines for allergies
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Acromegaly
Pituitary adenomas and pituitary hyperfunction: Clinical
Protein synthesis inhibitors: Aminoglycosides
Antituberculosis medications
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Miscellaneous protein synthesis inhibitors
Mechanisms of antibiotic resistance
Integrase and entry inhibitors
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Hepatitis medications
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Neuraminidase inhibitors
Herpesvirus medications
Azoles
Echinocandins
Miscellaneous antifungal medications
Antimalarials
Light microscopy and staining methods
Cardiac muscle histology
Artery and vein histology
Arteriole, venule and capillary histology
Pituitary gland histology
Pancreas histology
Eye and ear histology
Gallbladder histology
Esophagus histology
Small intestine histology
Liver histology
Spleen histology
Lymph node histology
Skeletal muscle histology
Ureter, bladder and urethra histology

Transcript

Watch video only

Content Reviewers

Disability-adjusted life years or DALYs are a measurement of disease burden, which is the impact of a health problem on an individual or in a population.

Typically, disability-adjusted life years are used to compare the burden of two diseases, like type II diabetes - which is a chronic condition where the body doesn’t produce enough insulin - and malaria - which is an infectious disease spread by mosquitoes that causes a person to have flu-like symptoms.

These two diseases are usually hard to compare because they affect different populations, have different short-term and long-term complications, and are managed completely differently.

So, to compare the two diseases, you could calculate the disability-adjusted life years for both diabetes and malaria, and the disease with the highest disability-adjusted life years has the highest disease burden.

Disability-adjusted life years are particularly useful for helping determine how resources should be allocated to a specific health issue.

For example, if you have 100 thousand dollars to donate, do you want to spend it towards helping people with type II diabetes in Canada or helping people with malaria in India?

So let’s try to calculate the disability-adjusted life years for diabetes in Canada, and that requires knowing two things.

First, you need to know the years of life lost to premature death, or YLL.

The years of life lost is calculated by multiplying the number of deaths that were the result of the disease (N), and the standard life expectancy at the age of death (L).

The standard life expectancy is just the average life expectancy in a population minus the age of the person who died.

For example, the average life expectancy in Canada is 82 years old, so the standard life expectancy of a person at age 60 is 22 years, because 82 minus 60 is 22. And if we’re only talking about 1 person who died, the number of deaths is 1.

So the years of life lost for a 60-year-old person that died from diabetes would be 1 times 22, or 22 years.

Calculating the years of life lost for an entire population gets a little more complicated, since a population is usually made up of people in different age groups.

For example, let’s say you want to figure out the burden of diabetes in a population of 4,000 people randomly selected in Canada.

So, you recruit 1,000 individuals in each of the 4 different age categories - 0 to 19, 20 to 49, 50 to 79, and above 80 - and follow them for 10 years.

You find out that there was 1 death from diabetes in the youngest age group, then 3, 4, and 7 deaths in the older age groups.

You also find that the average age of death for each age group is 19, 40, 65, and 81, so you’re able to calculate the average life expectancy at the age of death using the average life expectancy in Canada - which is 82. So 82 minus 19 is 63; 82 minus 40 is 42; 82 minus 65 is 17; and 82 minus 81 is 1.

Finally, you can calculate the years of life lost in each age group by multiplying the number of deaths in each age group by the average life expectancy for each age group. So, 1 times 63 is 63; 3 times 42 is 126; 4 times 17 is 68; and 7 times 1 is 7.

When you add up all of the years of life lost in each age group, the total number of years of life lost is 264.

The second thing you need to calculate the disability-adjusted life years is the number of years lost due to disability, which is sometimes referred to as the years lived with disability, or YLD.

The years lost due to disability is calculated by multiplying the incidence rate of the disease - which is the number of new cases of the disease that occurred within a certain time period - the length or duration of disease - which is the average length of time a person had the disease before dying, and the disability weight - which is a number assigned to each disease that represents the severity of the disease, or how much a disease affects how a person lives their life.

Disability weights range between 0 and 1, and in general, diseases with a score of 0 don’t limit a person’s ability to participate in any recreational, educational, procreational, or occupational activities.

People with diseases that have disability weights of 0.2 to 0.6 tend to have limited ability in some or all of those activities, and people with diseases that have disability scores of 0.8 or above typically need assistance with some or most daily activities.

For example, let’s say the disability weight for diabetes is 0.5. To calculate the years lost due to disability for a person in Canada who was diagnosed with diabetes at age 50, lived with diabetes for 10 years, and died at age 60, you would multiply the incidence - which would just be 1 in this case - times the duration - or 10 years - times the disability weight - or 0.5, which equals 5 years.

To calculate the number of years lost due to disability in a population you have to add up each of the years lost due to disability for each age group.

For example, let’s say that in 0-19 age group, there were 2 new cases of diabetes in the ten years of follow-up, so the incidence rate is 2 cases per 10 years for the youngest age group, and 9, 30, and 18 for the other age groups.

To figure out the average duration, you’d have to add up the number of years each person had diabetes until they died or until they moved into another age group.

Key Takeaways

The Disability-Adjusted Life Year (DALY) and Quality-Adjusted Life Year (QALY) are measures of population health used to quantify the burden of disease and injury. A DALY is a measure of lost healthy life years, while a QALY is a measure of how many years of life are lived in good health. Both measures incorporate the severity and duration of illness or injury and the age at which it occurs. They can be used to compare different diseases or injuries, or to compare the burden of disease between different populations.